| 中文名称 | 倍氯米松 |
| 英文名称 | BECLOMETHASONE |
| CAS号 | 4419-39-0 |
| 分子式 | C22H29ClO5 |
| 分子量 | 408.92 |
| EINECS号 | 224-585-9 |
| 熔点 | 217- 222°C (dec.) |
| 沸点 | 600.2±55.0 °C(Predicted) |
| 密度 | 1.35±0.1 g/cm3(Predicted) |
| 溶解度 | 二恶烷(少量,超声处理)、DMSO(少量溶解)、乙酸乙酯(少量溶解)、甲烷 |
| 形态 | 固体 |
| 酸度系数(pKa) | 12.17±0.70(Predicted) |
| 颜色 | 白色至浅棕色 |
| 默克索引编号 | 13,1020 |
| 稳定性 | 吸湿性 |
| 安全说明 | 24/25 |
| WGK Germany | 3 |
| 海关编码 | 29372900 |
Glucocorticoid Receptor
An inhibition of the normal physiological neutrophil migration and of neutrophil chemotaxis directed by wounding-induced inflammation is detected at 4 h after administration of 25 μM Beclomethasone. Tumour cell invasion and micrometastasis is also reduced in embryos incubated in 25 μM Beclomethasone 4 h before implantation. In addition, the lysyl oxidase inhibitor β-aminoproprionitrile (βAPN) largely reduces fibrillar collagen and enhances the CHT-TF transmigration of neutrophils, leading to a significant increase of tumour cell invasion and subsequent formation of micrometastases. Notably, βAPN inhibits neutrophil chemotaxis induced by inflammation, indicating that the increase of tumour cell invasion in βAPN-treated embryos is correlated with enhanced non-pathological neutrophil migration, but not with inflammation.